Drug development describes the process of developing a new drug that effectively targets a specific weakness in a cell. This process involves specific pre-clinical development and testing, followed by ...

Designing an efficient platform is crucial for any industrial process. This design process is known as process development, and it has become increasingly important in the pharmaceutical industry at ...

The Food and Drug Administration is launching a pilot program intended to speed up the process of bringing new drug ...

Continuous process improvement can benefit all aspects of life — from personal New Year’s resolutions to complex drug development. In a world where two-thirds of planned improvement initiatives fail, ...

The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors and the general public. Researchers have applied ...

Novo Nordisk is turning to Anthropic’s Claude models in a bid to cut the time needed to develop new medicines and bring them to market. The pharmaceutical giant said Wednesday that the partnership ...

The Food and Drug Administration (FDA) development and approval process for drugs and medical devices involves multiple phases that ensure the safety and effectiveness of products before and after ...

Dublin, Sept. 21, 2026 (GLOBE NEWSWIRE) -- "3 Day Virtual Session Live - The Drug Development Process from Concept to Market (Aug 10th - Aug 12th, 2026)" has been added to ResearchAndMarkets.com's ...

In this free webinar, learn how residual reagents and impurities can be identified, assessed and controlled throughout drug development. The featured speakers will discuss risk-based analytical ...

Hello, I'm Yuki. I work as a process chemist at a pharmaceutical company.When people think of jobs in pharmaceutical companies that utilize organic chemistry, most probably think of 'drug discovery ...

Some drugs may seem like they were named by throwing darts at the alphabet – but the process of drug naming is actually very intentional. In an interview with Fox News Digital, Dr. Dave Latshaw, CEO ...

Detailed analyses of ligand choice, linkage vector and linker length enabled the development of bitopic inhibitors of ABL1 and EGFR kinases, including an ABL1 inhibitor with enhanced activity against ...